Chart, page-3472

I work in neuromusculoskeletal medicine, have my own practice, and have a great working relationship with 4 nearby medical centres.

I have made my patients aware of the potential of this product, as well as some of the nearby GP's. The patients are excited and want to know where to get it from.

I have 1mill+ PAR shares and bought 20k more yesterday at $1.355.

I'm pretty confident that it will go to market, that it will benefit many patients, and many patients will absolutely "give it a go", even if they need to pay for it - clearly its not going to be beneficial on a symptomatic level for everyone. Word of mouth by patients will result in pressure on the GPs to learn about this product and prescribe it in the future.

OA is very debilitating and many of the baby boomers are pretty cashed up.

The biggest issues now are funding and slippage in timelines and also PR trying to convince the investment community that he has a competent board.